AI @ Pfizer

AI is actively reshaping cancer care with Pfizer leveraging AI to enhance early clinical trial patient identification, accelerate discovery, and broaden treatment access.

• Pfizer: How AI Is Already Reshaping Cancer Care

Pfizer backs Earendil, a biotech pioneering generative biology to accelerate biologics design; implements Pharma 5.0 vision with AI/ML automated visual inspection and manufacturing operations improvements.

• BioSpace: Backed by Sanofi, Pfizer, Earendil Bags $787M for AI-Driven Biologics Design
• Pfizer CentreOne: Embracing Pharma 5.0 for a Patient-Centered Future

Pfizer enhances AI-powered clinical trial recruitment feasibility and cost efficiency; hosts global AI Festival to boost AI fluency; pilots AI agents for procurement with human-in-the-loop oversight.

• Clinical Trial Vanguard: Pfizer's AI-Powered Feasibility and Cost Efficiency in Clinical Trial Recruitment
• Pfizer: Accelerating Innovation: Pfizer's 2025 AI Festival
• CPO Rising: Pfizer's Path to AI-Driven Procurement: From Automation to Intelligence

Pfizer demonstrates sustained AI leadership through extensive use in research, clinical trials, manufacturing, and marketing; engages in global educational AI initiatives featuring leaders like Sue Desmond-Hellman and Arianna Huffington.

• Pfizer Insights: Pioneering the Future of Healthcare: Pfizer's AI Advantage
• Pfizer: Pfizer Launches “Power of Knowing” Video Series
• Pfizer: Expanding Global Impact with Dr. Sue Desmond-Hellman
• Pfizer: The Power of Knowing, Episode 3: Arianna Huffington
• Chief AI Officer: How Pfizer Cut Drug Discovery Time From Years to 30 Days

Pfizer's strategic collaboration with XtalPi deploys AI platforms for small-molecule discovery; AI-enabled cost savings initiatives identify $1.2 billion in cuts; advances made in AI-driven procurement and global patient programs.

• PR Newswire: XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery
• FirstWord Pharma: Pfizer finds another $1.2B in cuts by tapping AI, automation
• Fierce Biotech: Pfizer expands XtalPi AI-powered small-molecule discovery collaboration
• Chief AI Officer: How Pfizer Cut Drug Discovery Time From Years to 30 Days and What Every CEO Can Learn
• ProjectPro: How to Build Real-Time AI Agents with Langchain MCP?

Expanded AI partnerships with PostEra utilizing generative chemistry accelerate medicinal design by ~40%; launch of generative AI powered consumer health Q&A and AI in pharmaceutical manufacturing improvements.

• Chemical & Engineering News: Pfizer doubles down on AI partnership with antibody-drug conjugate startup PostEra
• Pfizer: A New Consumer Digital Product Providing Answers You Can Trust
• Cleverence: How Johnson & Johnson and Pfizer Use AI to Enhance Pharmaceutical Production Efficiency
• HealthTech Magazine: How AI Drug Manufacturing Is Changing the Game

Pfizer solidified leadership in AI drug discovery achieving accelerated COVID breakthrough and 12% clinical trial failure rate reduction; partnerships and ML hub foster innovation.

• Virtasant: Pfizer's AI Drug Discovery Cuts Years Off Development Time

Appointment of Berta Rodriguez-Hervas as Chief AI and Analytics Officer to enhance global AI strategy; reports highlight AI potential to accelerate drug market entry.

• Technology Magazine: New AI Chief at Pfizer to Boost Digital Innovation
• American Healthcare Leader: AI Helps Pfizer Write the Future of Bringing Drugs to Market

Public-private AI collaborations advance drug discovery with new AI-driven platforms for small molecule interactions (CeMM collaboration) and AI-powered compliance copilots.

• Fierce Biotech: Pfizer collab with CeMM leads to new drug discovery AI method
• PharmaLeaders: Pfizer Leads the Way for AI-Powered Compliance Copilots
• BioSpace: Physicians in the US and UK believe Pfizer is leading the industry in AI/Machine Learning

Launch of 'Charlie,' a generative AI marketing platform increasing content creation up to 5x and accelerating regulatory approvals 2-3x; expanded AI use in clinical trial data oversight and personalized marketing.

• Pharmiweb: How Pfizer is Revolutionising Pharma Marketing with AI
• Digiday: With 'Charlie,' Pfizer is building a new generative AI platform for pharma marketing
• Clinical Trial Vanguard: How Pfizer Uses AI to Transform Clinical Trial Data Oversight

Public release of Pfizer's AI policy and expansion into generative AI across 17 use cases improved innovation and productivity.

• Pfizer: Policy Position on Artificial Intelligence
• CIO.inc: How Gen AI Is Helping Pfizer Change Healthcare Narrative

Pfizer intensified AI/ML efforts to accelerate transformative medicine delivery, scaling initiatives across teams.

• BioSpace: Pfizer Doubles Down on AI/ML to Bring Transformative Medicines to Patients

Published AI use cases illustrating practical applications supporting Pfizer’s immediate business goals including R&D and marketing.

• Emerj AI Research: Artificial Intelligence at Pfizer - 3 Use Cases

Pfizer publicized the use of AI and supercomputing to expedite vaccine and medicine discovery, marking increased strategic investment in AI capabilities.

• Pfizer Insights: Pfizer Is Using AI to Discover Breakthrough Medicines

Early AI exploration by Pfizer included a collaboration in 2016 using IBM Watson's machine learning and NLP to enhance pharmaceutical processes.

• BioPharma Dive: Pharma and AI? Let's try augmented intelligence first